Principal Financial Group Inc Surface Oncology, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.42 - $3.15 $62,629 - $138,930	-44,105 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$2.65 - $5.08 $53,137 - $101,864	-20,052 Reduced 31.25%	44,105 $130,000
Q4 2021 Feb 09, 2022	SELL	$4.73 - $7.9 $448,806 - $749,591	-94,885 Reduced 59.66%	64,157 $307,000
Q3 2021 Nov 09, 2021	SELL	$5.16 - $7.98 $12,585 - $19,463	-2,439 Reduced 1.51%	159,042 $1.2 Million
Q2 2021 Aug 10, 2021	BUY	$6.45 - $9.09 $1.04 Million - $1.47 Million	161,481 New	161,481 $1.2 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.